Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hechler, B.
Right arrow Articles by Gachet, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hechler, B.
Right arrow Articles by Gachet, C.
Related Collections
Right arrow Hemostasis, Thrombosis, and Vascular Biology
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

arrow to previous article Previous Article  |  Table of Contents  |  Next Article next article arrow

The P2Y1 Receptor Is Necessary for Adenosine 5'-Diphosphate-Induced Platelet Aggregation

Béatrice Hechler, Catherine Léon, Catherine Vial, Paul Vigne, Christian Frelin, Jean-Pierre Cazenave, and Christian Gachet

From INSERM U.311, Etablissement de Transfusion Sanguine de Strasbourg, Strasbourg, Cédex, France; and Institut de Pharmacologie Moléculaire et Cellulaire, CNRS UPR 411, Valbonne, France.

The human P2Y1 receptor heterologously expressed in Jurkat cells behaves as a specific adenosine 5'-diphosphate (ADP) receptor at which purified adenosine triphosphate (ATP) is an ineffective agonist, but competitively antagonizes the action of ADP. This receptor is thus a good candidate to be the elusive platelet P2T receptor for ADP. In the present work, we examined the effects on ADP-induced platelet responses of two selective and competitive P2Y1 antagonists, adenosine-2'-phosphate-5'-phosphate (A2P5P) and adenosine-3'-phosphate-5'-phosphate (A3P5P). Results were compared with those for the native P2Y1 receptor expressed on the B10 clone of rat brain capillary endothelial cells (BCEC) and for the cloned human P2Y1 receptor expressed on Jurkat cells. A2P5P and A3P5P inhibited ADP-induced platelet shape change and aggregation (pA2 = 5) and competitively antagonized calcium movements in response to ADP in fura-2-loaded platelets, B10 cells, and P2Y1-Jurkat cells. In contrast, these compounds had no effect on ADP-induced inhibition of adenylyl cyclase in platelets or B10 cells, whereas known antagonists of platelet activation by ADP such as Sp-ATPalpha S were effective. These identical signaling responses and pharmacologic properties suggest that platelets and BCEC share a common P2Y1 receptor involved in ADP-induced aggregation and vasodilation, respectively. This P2Y1 receptor coupled to the mobilization of intracellular calcium stores was found to be necessary to trigger ADP-induced platelet aggregation. The present results, together with data from the literature, also point to the existence of another as yet unidentified ADP receptor, coupled to adenylyl cyclase and responsible for completion of the aggregation response. Thus, the term, P2T, should no longer be used to designate a specific molecular entity.

Blood, Vol. 92 No. 1 (July 1), 1998: pp. 152-159
© 1998 by The American Society of Hematology.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Circ. Res.Home page
S. Offermanns
Activation of Platelet Function Through G Protein-Coupled Receptors
Circ. Res., December 8, 2006; 99(12): 1293 - 1304.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart J SupplHome page
B. Ibanez, G. Vilahur, and J. J. Badimon
Pharmacology of thienopyridines: rationale for dual pathway inhibition
Eur. Heart J. Suppl., October 1, 2006; 8(suppl_G): G3 - G9.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
N. Wettschureck and S. Offermanns
Mammalian G Proteins and Their Cell Type Specific Functions
Physiol Rev, October 1, 2005; 85(4): 1159 - 1204.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
G. Tolhurst, C. Vial, C. Leon, C. Gachet, R. J. Evans, and M. P. Mahaut-Smith
Interplay between P2Y1, P2Y12, and P2X1 receptors in the activation of megakaryocyte cation influx currents by ADP: evidence that the primary megakaryocyte represents a fully functional model of platelet P2 receptor signaling
Blood, September 1, 2005; 106(5): 1644 - 1651.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
A. Baurand, A. Eckly, B. Hechler, G. Kauffenstein, J.-L. Galzi, J.-P. Cazenave, C. Leon, and C. Gachet
Differential Regulation and Relocalization of the Platelet P2Y Receptors after Activation: A Way to Avoid Loss of Hemostatic Properties?
Mol. Pharmacol., March 1, 2005; 67(3): 721 - 733.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. Martinez-Pinna, I. S. Gurung, C. Vial, C. Leon, C. Gachet, R. J. Evans, and M. P. Mahaut-Smith
Direct Voltage Control of Signaling via P2Y1 and Other G{alpha}q-coupled Receptors
J. Biol. Chem., January 14, 2005; 280(2): 1490 - 1498.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
C. Leon, M. Alex, A. Klocke, E. Morgenstern, C. Moosbauer, A. Eckly, M. Spannagl, C. Gachet, and B. Engelmann
Platelet ADP receptors contribute to the initiation of intravascular coagulation
Blood, January 15, 2004; 103(2): 594 - 600.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
E. T. Bodor, G. L. Waldo, S. B. Hooks, J. Corbitt, J. L. Boyer, and T. K. Harden
Purification and Functional Reconstitution of the Human P2Y12 Receptor
Mol. Pharmacol., November 1, 2003; 64(5): 1210 - 1216.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
P. Fontana, A. Dupont, S. Gandrille, C. Bachelot-Loza, J.-L. Reny, M. Aiach, and P. Gaussem
Adenosine Diphosphate-Induced Platelet Aggregation Is Associated With P2Y12 Gene Sequence Variations in Healthy Subjects
Circulation, August 26, 2003; 108(8): 989 - 995.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
Y. M. Patel, K. Patel, S. Rahman, M. P. Smith, G. Spooner, R. Sumathipala, M. Mitchell, G. Flynn, A. Aitken, and G. Savidge
Evidence for a role for G{alpha}i1 in mediating weak agonist-induced platelet aggregation in human platelets: reduced G{alpha}i1 expression and defective Gi signaling in the platelets of a patient with a chronic bleeding disorder
Blood, June 15, 2003; 101(12): 4828 - 4835.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
B. Nieswandt, V. Schulte, A. Zywietz, M.-P. Gratacap, and S. Offermanns
Costimulation of Gi- and G12/G13-mediated Signaling Pathways Induces Integrin alpha IIbbeta 3 Activation in Platelets
J. Biol. Chem., October 11, 2002; 277(42): 39493 - 39498.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
P. Lova, S. Paganini, F. Sinigaglia, C. Balduini, and M. Torti
A Gi-dependent Pathway Is Required for Activation of the Small GTPase Rap1B in Human Platelets
J. Biol. Chem., March 29, 2002; 277(14): 12009 - 12015.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
J. Jin, T. M. Quinton, J. Zhang, S. E. Rittenhouse, and S. P. Kunapuli
Adenosine diphosphate (ADP)-induced thromboxane A2 generation in human platelets requires coordinated signaling through integrin alpha IIbbeta 3 and ADP receptors
Blood, January 1, 2002; 99(1): 193 - 198.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
N. A. Turner, J. L. Moake, and L. V. McIntire
Blockade of adenosine diphosphate receptors P2Y12 and P2Y1 is required to inhibit platelet aggregation in whole blood under flow
Blood, December 1, 2001; 98(12): 3340 - 3345.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
B. Hechler, P. Toselli, C. Ravanat, C. Gachet, and K. Ravid
Mpl Ligand Increases P2Y1 Receptor Gene Expression in Megakaryocytes with No Concomitant Change in Platelet Response to ADP
Mol. Pharmacol., November 1, 2001; 60(5): 1112 - 1120.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
R. A. Nicholas
Identification of the P2Y12 Receptor: A Novel Member of the P2Y Family of Receptors Activated by Extracellular Nucleotides
Mol. Pharmacol., September 1, 2001; 60(3): 416 - 420.
[Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
J. Takasaki, M. Kamohara, T. Saito, M. Matsumoto, S.-i. Matsumoto, T. Ohishi, T. Soga, H. Matsushime, and K. Furuichi
Molecular Cloning of the Platelet P2TAC ADP Receptor: Pharmacological Comparison with Another ADP Receptor, the P2Y1 Receptor
Mol. Pharmacol., September 1, 2001; 60(3): 432 - 439.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
G. Vassort
Adenosine 5'-Triphosphate: a P2-Purinergic Agonist in the Myocardium
Physiol Rev, April 1, 2001; 81(2): 767 - 806.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
C. Leon, M. Freund, C. Ravanat, A. Baurand, J.-P. Cazenave, and C. Gachet
Key Role of the P2Y1 Receptor in Tissue Factor-Induced Thrombin-Dependent Acute Thromboembolism : Studies in P2Y1-Knockout Mice and Mice Treated With a P2Y1 Antagonist
Circulation, February 6, 2001; 103(5): 718 - 723.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
The Clopidogrel in Unstable angina to prevent Recurrent Events (CURE) trial programme. Rationale, design and baseline characteristics including a meta-analysis of the effects of thienopyridines in vascular disease
Eur. Heart J., December 2, 2000; 21(24): 2033 - 2041.
[Abstract] [PDF]


Home page
BloodHome page
M.-P. Gratacap, J.-P. Herault, C. Viala, A. Ragab, P. Savi, J.-M. Herbert, H. Chap, M. Plantavid, and B. Payrastre
Fcgamma RIIA requires a Gi-dependent pathway for an efficient stimulation of phosphoinositide 3-kinase, calcium mobilization, and platelet aggregation
Blood, November 15, 2000; 96(10): 3439 - 3446.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
M. Cattaneo, A. Lecchi, R. Lombardi, C. Gachet, and M. L. Zighetti
Platelets From a Patient Heterozygous for the Defect of P2CYC Receptors for ADP Have a Secretion Defect Despite Normal Thromboxane A2 Production and Normal Granule Stores : Further Evidence That Some Cases of Platelet 'Primary Secretion Defect' Are Heterozygous for a Defect of P2CYC Receptors
Arterioscler. Thromb. Vasc. Biol., November 1, 2000; 20 (11): e101 - e106.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
P. Ohlmann, A. Eckly, M. Freund, J.-P. Cazenave, S. Offermanns, and C. Gachet
ADP induces partial platelet aggregation without shape change and potentiates collagen-induced aggregation in the absence of Galpha q
Blood, September 15, 2000; 96(6): 2134 - 2139.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
Y. Kawashima, T. Nagasawa, and H. Ninomiya
Contribution of ecto-5'-nucleotidase to the inhibition of platelet aggregation by human endothelial cells
Blood, September 15, 2000; 96(6): 2157 - 2162.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
I. M. B. Francischetti, J. M. C. Ribeiro, D. Champagne, and J. Andersen
Purification, Cloning, Expression, and Mechanism of Action of a Novel Platelet Aggregation Inhibitor from the Salivary Gland of the Blood-sucking Bug, Rhodnius prolixus
J. Biol. Chem., April 21, 2000; 275(17): 12639 - 12650.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
C. Trumel, B. Payrastre, M. Plantavid, B. Hechler, C. Viala, P. Presek, E. A. Martinson, J.-P. Cazenave, H. Chap, and C. Gachet
A Key Role of Adenosine Diphosphate in the Irreversible Platelet Aggregation Induced by the PAR1-Activating Peptide Through the Late Activation of Phosphoinositide 3-Kinase
Blood, December 15, 1999; 94(12): 4156 - 4165.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
M. J. Quinn and D. J. Fitzgerald
Ticlopidine and Clopidogrel
Circulation, October 12, 1999; 100(15): 1667 - 1672.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
M. Cattaneo and C. Gachet
ADP Receptors and Clinical Bleeding Disorders
Arterioscler. Thromb. Vasc. Biol., October 1, 1999; 19(10): 2281 - 2285.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
M. Bauer, M. Retzer, J. I. Wilde, P. Maschberger, M. Essler, M. Aepfelbacher, S. P. Watson, and W. Siess
Dichotomous Regulation of Myosin Phosphorylation and Shape Change by Rho-Kinase and Calcium in Intact Human Platelets
Blood, September 1, 1999; 94(5): 1665 - 1672.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
J. Geiger, J. Brich, P. Honig-Liedl, M. Eigenthaler, P. Schanzenbacher, J. M. Herbert, and U. Walter
Specific Impairment of Human Platelet P2YAC ADP Receptor–Mediated Signaling by the Antiplatelet Drug Clopidogrel
Arterioscler. Thromb. Vasc. Biol., August 1, 1999; 19(8): 2007 - 2011.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. L. Yap, S. C. Hughan, S. L. Cranmer, W. S. Nesbitt, M. M. Rooney, S. Giuliano, S. Kulkarni, S. M. Dopheide, Y. Yuan, H. H. Salem, et al.
Synergistic Adhesive Interactions and Signaling Mechanisms Operating between Platelet Glycoprotein Ib/IX and Integrin alpha IIbbeta 3. STUDIES IN HUMAN PLATELETS AND TRANSFECTED CHINESE HAMSTER OVARY CELLS
J. Biol. Chem., December 22, 2000; 275(52): 41377 - 41388.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
L. M. Schwiebert, W. C. Rice, B. A. Kudlow, A. L. Taylor, and E. M. Schwiebert
Extracellular ATP signaling and P2X nucleotide receptors in monolayers of primary human vascular endothelial cells
Am J Physiol Cell Physiol, February 1, 2002; 282(2): C289 - C301.
[Abstract] [Full Text] [PDF]



 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
  Copyright © 1998 by American Society of Hematology         Online ISSN: 1528-0020